Free tool
Stocks listed on Nasdaq GS
We cover 148 companies listed on Nasdaq GS. The median market value in the group is $664.14M. Across the group, the median move over the past trading day is −0.57%. 62% of the 138 with a 200-day average trade above it. Price change over the past year runs from −38.3% to +157.2% across the middle 80 percent of the group, with a median of +17.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
148 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| PGNY | Progyny, Inc. | $26.37 | −14.27% | +2.45% | +14.55% |
| TSHA | Taysha Gene Therapies, Inc. | $6.02 | +10.26% | +14.67% | +102.69% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| LKFT | Lakefront Biotherapeutics NV | $29.16 | +3.59% | −11.56% | −11.39% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.49 | +14.43% | −16.90% | −28.63% |
| SGRY | Surgery Partners, Inc. | $14.04 | −9.88% | −7.99% | −38.48% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% |
| FTRE | Fortrea Holdings Inc. | $18.53 | −10.48% | +10.23% | +105.20% |
| ANAB | AnaptysBio, Inc. | $58.00 | +11.30% | +93.55% | +326.47% |
| AVLN | Avalyn Pharma Inc. | $37.04 | +33.29% | +25.60% | +25.60% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.68 | +5.34% | +18.10% | +8.64% |
| ABSI | Absci Corporation | $9.22 | +29.31% | +155.40% | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $44.19 | +5.59% | +132.58% | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% |
| TYRA | Tyra Biosciences, Inc. | $26.22 | −15.09% | −2.13% | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% |
| INVA | Innoviva, Inc. | $21.24 | −2.61% | +6.89% | +7.06% |
| OMCL | Omnicell, Inc. | $33.45 | −22.30% | −25.90% | +0.66% |
| NVAX | Novavax, Inc. | $9.21 | +24.97% | +29.17% | +21.50% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AKTS | Aktis Oncology, Inc. | $26.51 | +15.41% | +18.35% | +18.35% |
| AZTA | Azenta, Inc. | $33.57 | +16.04% | +0.54% | +11.16% |
| OMDA | Omada Health, Inc. | $23.96 | +17.28% | +60.81% | +2.74% |
| SDGR | Schrödinger, Inc. | $19.47 | +27.34% | +8.29% | −1.62% |
| ATEC | Alphatec Holdings, Inc. | $9.42 | +1.07% | −54.62% | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| PNTG | The Pennant Group, Inc. | $38.28 | −8.90% | +37.55% | +56.31% |
| IART | Integra LifeSciences Holdings Corporation | $16.88 | −14.57% | +40.55% | +13.52% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $3.65 | +16.99% | +32.73% | −18.89% |
| CERT | Certara, Inc. | $8.22 | +3.92% | −5.95% | −25.07% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| SVRA | Savara Inc. | $5.61 | +5.25% | −0.53% | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $11.96 | +9.02% | −31.85% | −35.42% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| SLDB | Solid Biosciences Inc. | $9.72 | +21.96% | +78.35% | +72.95% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $25.90 | −3.39% | +5.89% | −0.88% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| DSGN | Design Therapeutics, Inc. | $15.59 | +31.34% | +71.32% | +194.71% |
| BVS | Bioventus Inc. | $13.97 | +5.75% | +93.76% | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| ANNX | Annexon, Inc. | $4.99 | +0.40% | +6.40% | +136.49% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $22.02 | +9.28% | −16.78% | −27.78% |
| ACRS | Aclaris Therapeutics, Inc. | $6.19 | +16.14% | +114.93% | +240.11% |
| CBLL | CeriBell, Inc. | $23.45 | +31.52% | +10.09% | +102.16% |
| SGP | SpyGlass Pharma, Inc. | $26.64 | +23.22% | +0.91% | +0.91% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| INMD | InMode Ltd. | $14.93 | −3.49% | +0.88% | −1.71% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.56 | +57.97% | +112.57% | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $27.51 | −23.37% | −39.58% | −29.08% |
| HSTM | HealthStream, Inc. | $28.76 | −0.31% | +26.59% | +1.86% |
| STTK | Shattuck Labs, Inc. | $7.90 | +15.84% | +112.94% | +690.00% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.77 | −24.79% | −44.18% | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.29 | +12.89% | +0.47% | +240.48% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| AGMB | AgomAb Therapeutics NV | $14.28 | +13.88% | −2.53% | −2.53% |
| ZVRA | Zevra Therapeutics, Inc. | $11.74 | +20.66% | +40.77% | +25.43% |
| EVO | Evotec SE | $1.95 | −0.51% | −38.68% | −44.13% |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% |
| VALN | Valneva SE | $6.70 | +32.31% | −25.24% | −23.49% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% |
| MPLT | MapLight Therapeutics, Inc. | $12.86 | +4.47% | −23.32% | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $4.57 | +2.47% | −7.11% | +11.74% |
| RGNX | REGENXBIO Inc. | $9.38 | −2.29% | −30.88% | +6.35% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| CGC | Canopy Growth Corporation | $1.04 | +15.77% | −13.03% | −31.46% |
| EDIT | Editas Medicine, Inc. | $3.18 | +21.37% | +55.12% | +19.10% |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% |
| PACB | Pacific Biosciences of California, Inc. | $1.56 | +12.23% | −15.22% | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.38 | +18.70% | +22.82% | +21.09% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| PRTA | Prothena Corporation plc | $9.25 | +8.06% | +0.54% | +8.06% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| BIOA | BioAge Labs, Inc. | $9.84 | −55.11% | −23.30% | +107.59% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.51 | +22.17% | +58.33% | +53.06% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.15 | +12.21% | −1.87% | +65.89% |
| OFIX | Orthofix Medical Inc. | $9.75 | −20.47% | −34.30% | −34.30% |
| UPB | Upstream Bio, Inc. | $7.13 | +11.41% | −73.66% | −57.31% |
| MOBI | Mobia Medical, Inc. | $11.65 | +8.68% | −0.85% | −0.85% |
| SLP | Simulations Plus, Inc. | $18.41 | +0.44% | +1.66% | +28.20% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.25% | −46.55% | +37.32% |
| IFRX | InflaRx N.V. | $2.42 | +43.20% | +122.02% | +142.00% |
| TMCI | Treace Medical Concepts, Inc. | $4.72 | +17.71% | +88.80% | −36.39% |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $3.24 | +26.07% | −11.96% | −65.71% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| NMRA | Neumora Therapeutics, Inc. | $1.56 | −7.14% | −6.02% | −11.36% |
| ANIK | Anika Therapeutics, Inc. | $21.68 | +43.10% | +131.87% | +136.17% |
| EMBC | Embecta Corp. | $4.96 | +38.16% | −56.84% | −64.70% |
| PYXS | Pyxis Oncology, Inc. | $3.34 | +14.78% | +190.43% | +145.59% |
| ALXO | ALX Oncology Holdings Inc. | $1.98 | −0.50% | +72.17% | +65.00% |
| ALEC | Alector, Inc. | $2.46 | +61.84% | +60.78% | +2.50% |
| MGNX | MacroGenics, Inc. Common Stock | $4.04 | +4.94% | +150.93% | +134.88% |
| OSUR | OraSure Technologies, Inc. | $3.71 | −7.71% | +55.88% | +11.08% |
| LAB | Standard BioTools Inc. | $0.65 | −17.49% | −48.68% | −49.08% |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% |
| PEPG | PepGen Inc. | $3.22 | +75.96% | −55.09% | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $13.85 | +20.54% | −6.10% | −6.10% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $13.64 | +37.22% | −17.58% | −57.61% |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% |
| SPOK | Spok Holdings, Inc. | $10.42 | −4.36% | −15.28% | −36.39% |
| ABOS | Acumen Pharmaceuticals, Inc. | $2.99 | +31.14% | +48.02% | +115.11% |
| VYGR | Voyager Therapeutics, Inc. | $3.46 | +13.82% | −14.14% | +1.17% |
| ANTX | AN2 Therapeutics, Inc. | $5.53 | +17.66% | +398.20% | +385.09% |
| NKTX | Nkarta, Inc. | $2.63 | +18.47% | +40.64% | +17.41% |
| HUMA | Humacyte, Inc. | $0.68 | +8.02% | −30.09% | −55.45% |
| CDXS | Codexis, Inc. | $1.65 | +10.00% | +2.48% | −38.20% |
| OGI | Organigram Global Inc. | $1.26 | +32.77% | −27.17% | −24.55% |
| LFCR | Lifecore Biomedical, Inc. | $4.65 | +5.92% | −39.92% | −38.25% |
| MOLN | Molecular Partners AG | $4.45 | +16.19% | +5.45% | +18.67% |
| AARD | Aardvark Therapeutics, Inc. | $6.81 | +6.07% | −48.37% | −24.25% |
| INGN | Inogen, Inc. | $5.56 | −13.40% | −16.14% | −29.89% |
| MIST | Milestone Pharmaceuticals Inc. | $1.18 | +10.28% | −42.44% | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $4.78 | −18.71% | −70.12% | −87.21% |
| MXCT | MaxCyte, Inc. | $1.31 | +24.76% | −15.48% | −6.43% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.27 | +28.98% | −8.84% | −20.91% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| APYX | Apyx Medical Corporation | $3.05 | −20.98% | −12.86% | +54.04% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| HCAT | Health Catalyst, Inc. | $1.59 | −25.70% | −30.26% | −56.91% |
| SEER | Seer, Inc. | $2.02 | −5.61% | +10.99% | −1.94% |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.